Pharma industry updates advice on engaging with healthcare professionals as countries emerge from COVID-19 lockdown

Geneva, 28 May 2020: As countries lift lockdown restrictions, the international pharma industry body, IFPMA, provides its members with ethical considerations on when and how to resume in-person meetings with healthcare practitioners and other stakeholders within the healthcare system.

Please click here to read the full news release